Abstract | BACKGROUND: METHODS: RESULTS: In our series, the overall incidence of NMSC after transplantation was 2.2% (n = 39), and SCC represented the most frequent skin malignancy (64.1%), followed by BCC (17.9%), Bowen's disease (10.2%), basosquamous carcinoma (5.1%), and a rare case of invasive sebaceous carcinoma (2.6%). A shift to newer immunosuppressive regimens after the initial diagnosis of NMSC had been implemented in eight cases (20.5%). The recurrence rate after initial treatment was 41% (n = 16), and distant metastatic disease was diagnosed in 15.4% (n = 6) of NMSC patients. The NMSC-specific mortality rate was 25.6% (n = 10). CONCLUSIONS: Nonmelanoma skin cancer remains a significant source of morbidity and mortality in RTRs, and post-transplant surveillance should be increased.
|
Authors | George Zavos, Nikolaos P Karidis, Gerasimos Tsourouflis, John Bokos, Konstantinos Diles, George Sotirchos, Eleni Theodoropoulou, Alkiviadis Kostakis |
Journal | International journal of dermatology
(Int J Dermatol)
Vol. 50
Issue 12
Pg. 1496-500
(Dec 2011)
ISSN: 1365-4632 [Electronic] England |
PMID | 21790552
(Publication Type: Journal Article)
|
Copyright | © 2011 The International Society of Dermatology. |
Chemical References |
|
Topics |
- Adenocarcinoma, Sebaceous
(epidemiology, etiology)
- Adult
- Aged
- Carcinoma, Basal Cell
(epidemiology, etiology)
- Carcinoma, Squamous Cell
(epidemiology, etiology)
- Female
- Humans
- Immunosuppression Therapy
(adverse effects)
- Immunosuppressive Agents
(adverse effects)
- Incidence
- Kidney Transplantation
(adverse effects)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(epidemiology, etiology)
- Retrospective Studies
- Sebaceous Gland Neoplasms
(epidemiology, etiology)
- Skin Neoplasms
(epidemiology, etiology)
- Young Adult
|